Gabriela Tomescu
Corporate Officer/Principal bij Apneon, Inc.
Actieve functies van Gabriela Tomescu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Apneon, Inc.
 Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA. | Corporate Officer/Principal | 01-09-2005 | - |
Loopbaan van Gabriela Tomescu
Opleiding van Gabriela Tomescu
| The Ohio State University | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Georgetown University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Graduate Degree | 2 |
| Undergraduate Degree | 2 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Apneon, Inc.
Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA. | Health Technology |
- Beurs
- Insiders
- Gabriela Tomescu
- Ervaring
